Twenty-one patients with common carotid artery occlusion confirmed by both angiography and duplex scanning were followed prospectively for 50 months (mean) by repeated clinical and duplex examination. Intracranial vessels were investigated in 16 patients using transcranial Doppler sonography and compared with an age-matched group of controls with normal angiographic findings. A patent bifurcation was found in 12 common carotid artery occlusions, in 10 of these flow was maintained from the external to the internal carotid artery, and in 2 the flow direction was opposite. In 10 instances both internal and common carotid arteries were occluded. Maximal and mean velocities in the middle cerebral artery were 64 ± 22 and 43 ± 16 cm/s on the occluded side, 85 ± 44 and 52 ± 23 cm/s on the non-occluded side, and 84 ± 12 and 56 ± 9 cm/s in controls (p < 0.05). Pulse curves in the middle cerebral artery had different shapes with significantly delayed pulse rise time (p < 0.01) and acceleration (p < 0.001, compared to the normal controls). Cross-over collaterals via the anterior cerebral artery were found only in association with stenosis < 75% on the contralateral side, whereas posterior collaterals were commoner if contralateral stenosis > 75% was present. Most patients with common carotid artery occlusion and patent bifurcation experienced attacks of amaurosis fugax and vertigo, but none with patent bifurcation and well-functioning intracranial collaterals had a major stroke. In contrast, 5 of 10 patients with combined internal and common carotid artery occlusion had a major stroke.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.